Clinical Trial Update: Assessing Refractoriness and Infectious Survival Events in AML

View source ↗

Summary

A completed AML clinical trial update focusing on refractoriness and infectious survival events.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Acute Myeloid Leukemia (AML) | Status: COMPLETED